← Open Payments lookup

JENNIFER CARMICHAEL: Open Payments

NPI 1669808341 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,787 in 42 payments from 11 companies in 2025. Trend: 2023 $1,374 · 2024 $1,484 · 2025 $1,787

Food & beverage: $1,688Education: $99
CompanyPaymentsAmount
ABBVIE INC.10$568
Janssen Biotech, Inc.4$292
Phathom Pharmaceuticals, Inc.7$231
GENZYME CORPORATION3$184
Aimmune Therapeutics, Inc.1$123
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$118
Takeda Pharmaceuticals U.S.A., Inc.4$110
PFIZER INC.5$98
Regeneron Healthcare Solutions, Inc.1$22
Ipsen Biopharmaceuticals, Inc1$22

Products named: TREMFYA, VOQUEZNA, DUPIXENT, RINVOQ, SKYRIZI, CREON, ZENPEP, XIFAXAN.

Industry payments across WA — which companies pay providers there.